Brisson, Marc

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M.-C., Baldo, V., Brassard, P., Brotherton, J. M. L., Callander, D., et al. (2019) · The Lancet

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 1,384

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 943

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T. N., Bénard, É., et al. (2020) · The Lancet

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 650

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

Brisson, M., Bénard, É., Drolet, M., Bogaards, J. A., Baussano, I., Vänskä, S., Jit, M., Boily, M.-C., Smith, M. A., Berkhof, J., et al. (2016) · The Lancet Public Health

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 307

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet

Vaccine Coverage and HesitancyImmune responses and vaccinations

Cited by 300

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study

Jit, M., Brisson, M., Portnoy, A., & Hutubessy, R. (2014) · The Lancet Global Health

Cervical Cancer and HPV ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 261

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status

Looker, K. J., Rönn, M. M., Brock, P. M., Brisson, M., Drolet, M., Mayaud, P., & Boily, M. (2018) · Journal of the International AIDS Society

Cervical Cancer and HPV ResearchHIV/AIDS Research and Interventions

Cited by 185

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

Skowronski, D. M., Febriani, Y., Ouakki, M., Setayeshgar, S., El Adam, S., Zou, M., Talbot, D., Prystajecky, N., Tyson, J. R., Gilca, R., et al. (2022) · Clinical Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 155

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

Van de Velde, N., Boily, M.-C., Drolet, M., Franco, E. L., Mayrand, M.-H., Kliewer, E. V., Coutlée, F., Laprise, J.-F., Malagón, T., & Brisson, M. (2012) · JNCI: Journal of the National Cancer Institute

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 140

Global elimination of cervical cancer as a public health problem

Brisson, M., & Drolet, M. (2019) · The Lancet Oncology

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 118

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Whitworth, H. S., Gallagher, K. E., Howard, N., Mounier-Jack, S., Mbwanji, G., Kreimer, A. R., Basu, P., Kelly, H., Drolet, M., Brisson, M., et al. (2020) · Vaccine

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 118

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

Brisson, M., & Edmunds, W. J. (2006) · Medical Decision Making

Health Systems, Economic Evaluations, Quality of LifeHerpesvirus Infections and Treatments

Cited by 109

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis

Drolet, M., Laprise, J.-F., Martin, D., Jit, M., Bénard, É., Gingras, G., Boily, M.-C., Alary, M., Baussano, I., Hutubessy, R., et al. (2021) · The Lancet Infectious Diseases

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 99

Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis.

Van de Velde, N., Brisson, M., & Boily, M.-C. (2010) · Vaccine

Cervical Cancer and HPV ResearchMathematical and Theoretical Epidemiology and Ecology Models

Cited by 87

HPV-FRAME: a consensus statement and quality framework for modelled evaluations of HPV-related cancer control

Canfell, K., Kim, J. J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J. A., Campos, N., Jennett, C., Sharma, M., Simms, K. T., et al. (2019) · Papillomavirus Research

Cervical Cancer and HPV ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 68

Guidelines for multi-model comparisons of the impact of infectious disease interventions

den Boon, S., Jit, M., Brisson, M., Medley, G., Beutels, P., White, R., Flasche, S., Hollingsworth, T. D., Garske, T., Pitzer, V. E., et al. (2019) · BMC Medicine

Health Systems, Economic Evaluations, Quality of LifeMathematical and Theoretical Epidemiology and Ecology Models

Cited by 67

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study

Brisson, M., Laprise, J.-F., Drolet, M., Van de Velde, N., Franco, E. L., Kliewer, E. V., Ogilvie, G., Deeks, S. L., & Boily, M.-C. (2013) · Vaccine

Cervical Cancer and HPV ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 56

Human papillomavirus vaccination at a time of changing sexual behavior

Baussano, I., Lazzarato, F., Brisson, M., & Franceschi, S. (2016) · Emerging Infectious Diseases

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 24

Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9–14-year-old girls against human papillomavirus

Jit, M., & Brisson, M. (2018) · International Journal of Cancer

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 20